CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Operating expenses:
Research and development	$ 14,013	$ 16,783	$ 43,464	$ 53,351
Selling, general and administrative	17,786	16,155	56,558	58,247
Restructuring		1,600		3,728
Total operating expenses	31,799	34,538	100,022	115,326
Loss from operations	(961)	(5,243)	(12,776)	(31,029)
Non-operating expense, net:
Foreign exchange (loss) gain	(241)	166	(173)	22
Interest expense	(2,260)	(2,364)	(6,824)	(6,157)
Other income, net	604	233	1,468	1,159
Total non-operating expense, net	(1,897)	(1,965)	(5,529)	(4,976)
Loss before income taxes	(2,858)	(7,208)	(18,305)	(36,005)
Provision for income taxes	76	78	94	253
Net loss	(2,934)	(7,286)	(18,399)	(36,258)
Net loss attributable to noncontrolling interest		(19)	(2)	(97)
Net loss attributable to Cerus Corporation	$ (2,934)	$ (7,267)	$ (18,397)	$ (36,161)
Net loss per share attributable to Cerus Corporation
Basic	$ (0.02)	$ (0.04)	$ (0.1)	$ (0.2)
Diluted	$ (0.02)	$ (0.04)	$ (0.1)	$ (0.2)
Weighted average shares outstanding:
Basic	185,424	180,938	184,170	179,950
Diluted	185,424	180,938	184,170	179,950
Product
Revenue	$ 46,017	$ 39,772	$ 129,461	$ 109,599
Cost of revenue	19,818	17,956	57,324	49,158
Gross profit	26,199	21,816	72,137	60,441
Government Contract
Revenue	$ 4,639	$ 7,479	$ 15,109	$ 23,856